As β3-AR signaling regulates cardiac relaxation—notably through PKG-downstream signaling—and prevents hypertrophic remodeling, it recently appeared as a promising therapeutic target for HF with preserved ejection fraction (HFpEF). The gene discussed is ADRB3; the disease is hydrops fetalis.